CLAZF

CLARITAS PHARMACICLS INC by CLARITAS PHARMACEUTICALS INC. (CLAZF)

About CLARITAS PHARMACICLS INC by CLARITAS PHARMACEUTICALS INC. (CLAZF)

Claritas Pharmaceuticals, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.00
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
25
Avg. volume
195
P/E ratio
--

CLARITAS PHARMACICLS INC by CLARITAS PHARMACEUTICALS INC. News

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.00
52 Week Low
$0.00
Market cap
--
Dividend yield
0.00%
Volume
25
Avg. volume
195
P/E ratio
--